Medicina
Departament
SEGUNDO
GONZALEZ RODRIGUEZ
Catedrático de Universidad
Publicacions en què col·labora amb SEGUNDO GONZALEZ RODRIGUEZ (58)
2023
-
BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia
Cancer Immunology, Immunotherapy, Vol. 72, Núm. 7, pp. 2529-2539
-
Chemo-Immunotherapy: A New Trend in Cancer Treatment
Cancers, Vol. 15, Núm. 11
2022
-
RICORS2040: The need for collaborative research in chronic kidney disease
Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387
2021
-
Btla/hvem axis induces nk cell immunosuppression and poor outcome in chronic lymphocytic leukemia
Cancers, Vol. 13, Núm. 8
-
Checkpoint inhibition in the fight against cancer: NK cells have some to say in it
Successes and Challenges of NK Immunotherapy: Breaking Tolerance to Cancer Resistance (Elsevier), pp. 267-304
-
Lag‐3 blockade with relatlimab (Bms‐986016) restores anti‐leukemic responses in chronic lymphocytic leukemia
Cancers, Vol. 13, Núm. 9
2020
-
Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT
Bone Marrow Transplantation
-
Driver mutations and single copy number abnormalities identify binet stage a patients with chronic lymphocytic leukemia with aggressive progression
Journal of Clinical Medicine, Vol. 9, Núm. 11, pp. 1-8
-
Expression of CD47 antigen in Reed–Sternberg cells as a new potential biomarker for classical Hodgkin lymphoma
Clinical and Translational Oncology, Vol. 22, Núm. 5, pp. 782-785
-
Lectin-like transcript 1 (LLT1) checkpoint: A novel independent prognostic factor in HPV-negative oropharyngeal squamous cell carcinoma
Biomedicines, Vol. 8, Núm. 12, pp. 1-14
2019
-
Lectin-like transcript 1 (LLT1) expression is associated with nodal metastasis in patients with head and neck cutaneous squamous cell carcinoma
Archives of Dermatological Research, Vol. 311, Núm. 5, pp. 369-376
-
NK cell-based immunotherapy in cancer metastasis
Cancers, Vol. 11, Núm. 1
-
NK cells in the treatment of hematological malignancies
Journal of Clinical Medicine, Vol. 8, Núm. 10
-
The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling
Frontiers in Immunology, Vol. 10
2018
-
Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia
Frontiers in immunology, Vol. 9, pp. 2917
-
NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines
Cancer Research, Vol. 78, Núm. 14, pp. 3913-3925
2017
-
Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia
OncoImmunology, Vol. 6, Núm. 10
2016
-
Analysis of clinical prognostic variables for Chronic Lymphocytic Leukemia decision-making problems
Journal of Biomedical Informatics, Vol. 60, pp. 342-351
-
Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors
OncoImmunology, Vol. 5, Núm. 2
-
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
Journal of Immunology Research, Vol. 2016